These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 20218538)
1. Evaluation of quantitative structure-activity relationship modeling strategies: local and global models. Helgee EA; Carlsson L; Boyer S; Norinder U J Chem Inf Model; 2010 Apr; 50(4):677-89. PubMed ID: 20218538 [TBL] [Abstract][Full Text] [Related]
2. Local and global quantitative structure-activity relationship modeling and prediction for the baseline toxicity. Yuan H; Wang Y; Cheng Y J Chem Inf Model; 2007; 47(1):159-69. PubMed ID: 17238261 [TBL] [Abstract][Full Text] [Related]
3. Substance-tailored testing strategies in toxicology: an in silico methodology based on QSAR modeling of toxicological thresholds and Monte Carlo simulations of toxicological testing. Péry AR; Desmots S; Mombelli E Regul Toxicol Pharmacol; 2010 Feb; 56(1):82-92. PubMed ID: 19766156 [TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry tools: making sense of HTS data. Kolossov E; Lemon A Eur J Med Chem; 2006 Feb; 41(2):166-75. PubMed ID: 16368163 [TBL] [Abstract][Full Text] [Related]
5. Computational modeling of biologically active molecules using NMR spectra. Beger RD Drug Discov Today; 2006 May; 11(9-10):429-35. PubMed ID: 16635805 [TBL] [Abstract][Full Text] [Related]
7. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling. Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223 [TBL] [Abstract][Full Text] [Related]
8. Computational analysis of structure-activity relationships. Gedeck P; Kramer C; Ertl P Prog Med Chem; 2010; 49():113-60. PubMed ID: 20855040 [No Abstract] [Full Text] [Related]
9. Computational study of histamine H3-receptor antagonist with support vector machines and three dimension quantitative structure activity relationship methods. Chen HF Anal Chim Acta; 2008 Aug; 624(2):203-9. PubMed ID: 18706326 [TBL] [Abstract][Full Text] [Related]
10. Application of support vector machine (SVM) for prediction toxic activity of different data sets. Zhao CY; Zhang HX; Zhang XY; Liu MC; Hu ZD; Fan BT Toxicology; 2006 Jan; 217(2-3):105-19. PubMed ID: 16213080 [TBL] [Abstract][Full Text] [Related]
11. Prediction of toxicity of nitrobenzenes using ab initio and least squares support vector machines. Niazi A; Jameh-Bozorghi S; Nori-Shargh D J Hazard Mater; 2008 Mar; 151(2-3):603-9. PubMed ID: 17630186 [TBL] [Abstract][Full Text] [Related]
12. Fragment descriptors in structure-property modeling and virtual screening. Varnek A Methods Mol Biol; 2011; 672():213-43. PubMed ID: 20838971 [TBL] [Abstract][Full Text] [Related]
13. Global, local and novel consensus quantitative structure-activity relationship studies of 4-(Phenylaminomethylene) isoquinoline-1, 3 (2H, 4H)-diones as potent inhibitors of the cyclin-dependent kinase 4. Lei B; Xi L; Li J; Liu H; Yao X Anal Chim Acta; 2009 Jun; 644(1-2):17-24. PubMed ID: 19463556 [TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationship modeling of juvenile hormone mimetic compounds for Culex pipiens larvae, with a discussion of descriptor-thinning methods. Basak SC; Natarajan R; Mills D; Hawkins DM; Kraker JJ J Chem Inf Model; 2006; 46(1):65-77. PubMed ID: 16426041 [TBL] [Abstract][Full Text] [Related]
15. Computational studies of COX-2 inhibitors: 3D-QSAR and docking. Kim HJ; Chae CH; Yi KY; Park KL; Yoo SE Bioorg Med Chem; 2004 Apr; 12(7):1629-41. PubMed ID: 15028256 [TBL] [Abstract][Full Text] [Related]
16. Stochastic versus stepwise strategies for quantitative structure-activity relationship generation--how much effort may the mining for successful QSAR models take? Horvath D; Bonachera F; Solov'ev V; Gaudin C; Varnek A J Chem Inf Model; 2007; 47(3):927-39. PubMed ID: 17480052 [TBL] [Abstract][Full Text] [Related]
17. Computational methods to rationalize experimental strategies in biocatalysis. Braiuca P; Ebert C; Basso A; Linda P; Gardossi L Trends Biotechnol; 2006 Sep; 24(9):419-25. PubMed ID: 16870286 [TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists. Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422 [TBL] [Abstract][Full Text] [Related]